monoethylcholine has been researched along with Cancer of Prostate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behrendt, FF; Keil, S; Lensing, C; Mottaghy, FM; Verburg, FA | 1 |
1 other study(ies) available for monoethylcholine and Cancer of Prostate
Article | Year |
---|---|
No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
Topics: Aged; Choline; Contrast Media; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiation Dosage; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |